All Pharma News
CDE, China approved “Metformin Hydrochloride”

CDE, China approved “Metformin Hydrochloride”
PRESS RELEASE
19 Feb 2024
Share Share
Transcript of Earnings Conference Call, post declaration of audited financial results for the quarter and nine months ended 31 st December 2023

Transcript of Earnings Conference Call, post declaration of audited financial results for the quarter and nine months ended 31 st December 2023
PRESS RELEASE
14 Feb 2024
Share Share
Intimation under Regulation 39 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 39 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
PRESS RELEASE
13 Feb 2024
Share Share
Communication to Shareholders - Deduction of tax at source on Interim Dividend for FY 2023-24

Communication to Shareholders - Deduction of tax at source on Interim Dividend for FY 2023-24
PRESS RELEASE
10 Feb 2024
Share Share
Submission of newspaper publication of Audited Financial Results for the quarter and nine months ended 31st December 2023

Submission of newspaper publication of Audited Financial Results for the quarter and nine months ended 31st December 2023
PRESS RELEASE
07 Feb 2024
Share Share
IOL Chemicals and Pharmaceuticals net profit rises 43.5% in 9M FY24

IOL Chemicals and Pharmaceuticals net profit rises 43.5% in 9M FY24
INDIAN PHARMA POST
07 Feb 2024
Share Share
CEP Certificate for Losartan Potassium issued by EDQM

CEP Certificate for Losartan Potassium issued by EDQM
PRESS RELEASE
06 Feb 2024
Share Share
Outcome of the Board Meeting

Outcome of the Board Meeting
PRESS RELEASE
06 Feb 2024
Share Share
Schedule of analyst / investor conference call – Q3 & 9M FY24

Schedule of analyst / investor conference call – Q3 & 9M FY24
PRESS RELEASE
05 Feb 2024
Share Share
Intimation of lost share certificates

Intimation of lost share certificates
PRESS RELEASE
25 Jan 2024
Share Share